Massachusetts Gov. Charlie Baker announced a legislative proposal that would provide $500 million over five years for the life sciences sector, extending the state’s commitment to the biotech and medical technology industry. The money would be used for strategic investments in public infrastructure, research and development, workforce training and education. The proposal includes a $295 million bond authorization to provide capital funding, up to $150 million in job-creating tax incentives, and $55 million for the Investment Fund, which would be provided through the annual consolidated net surplus, the same funding mechanism as the current initiative.
